drugset / Trial / NCT00678756

Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol

NCT00678756

Phase 2 Unknown 12 enrolled Technical University Dresden
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Exploration of antipsoriatic effects of UVB-therapy +/- CYP-inhibitor Ketokonazol on affected psoriatic skin

Timeline

Start
2008-03
Primary completion
2009-10
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 2 % Topical

Indications